Stay up-to-date on the progress of dozens of vaccine candidates that are currently undergoing clinical testing.

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

Host vouchering, the practice of preserving species known to harbor infectious diseases, can be used to help determine a pathogen’s source, scientists say.

Knocking out the receptor for a lipid that causes inflammation rejuvenates macrophage metabolism and restores cognitive function in an Alzheimer’s disease model.

Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.

It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.

If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.

Five collaborations involving autistic scientists and experts are advancing autism research, from lending support for theories of the condition to shoring up trials of new treatments.

University of Connecticut entomologist David Wagner speaks with The Scientist about his biggest concerns for global insect populations and recommendations for actions to help save these tiny but important creatures.